{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:18Z","timestamp":1792783398163,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Albireo Pharma, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12325-022-02262-7","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T01:03:41Z","timestamp":1662426221000},"page":"5105-5125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8130-2024","authenticated-orcid":false,"given":"Chad","family":"Gwaltney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ivanescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Warholic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Kjems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"2262_CR1","unstructured":"Data on file. Boston: Albireo Pharma, Inc; 2022."},{"issue":"8","key":"2262_CR2","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/liv.14553","volume":"40","author":"BM Kamath","year":"2020","unstructured":"Kamath BM, Stein P, Houwen RHJ, Verkade HJ. Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis. Liver Int. 2020;40(8):1812\u201322. https:\/\/doi.org\/10.1111\/liv.14553.","journal-title":"Liver Int"},{"issue":"5","key":"2262_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12072-020-10070-w","volume":"14","author":"SJ Karpen","year":"2020","unstructured":"Karpen SJ, Kelly D, Mack C, Stein P. Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders. Hepatol Int. 2020;14(5):677\u201389. https:\/\/doi.org\/10.1007\/s12072-020-10070-w.","journal-title":"Hepatol Int"},{"key":"2262_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/hmer.S137209","volume":"10","author":"M Gunaydin","year":"2018","unstructured":"Gunaydin M, Bozkurter Cil AT. Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment. Hepatic Med. 2018;10:95\u2013104. https:\/\/doi.org\/10.2147\/hmer.S137209.","journal-title":"Hepatic Med"},{"issue":"2","key":"2262_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clinre.2017.08.007","volume":"42","author":"A Thebaut","year":"2018","unstructured":"Thebaut A, Debray D, Gonzales E. An update on the physiopathology and therapeutic management of cholestatic pruritus in children. Clin Res Hepatol Gastroenterol. 2018;42(2):103\u20139. https:\/\/doi.org\/10.1016\/j.clinre.2017.08.007.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"2262_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clinre.2010.10.007","volume":"35","author":"AE Kremer","year":"2011","unstructured":"Kremer AE, Oude Elferink RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol. 2011;35(2):89\u201397. https:\/\/doi.org\/10.1016\/j.clinre.2010.10.007.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"2262_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clinre.2018.07.010","volume":"43","author":"A Baker","year":"2019","unstructured":"Baker A, Kerkar N, Todorova L, Kamath BM, Houwen RHJ. Systematic review of progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol. 2019;43(1):20\u201336. https:\/\/doi.org\/10.1016\/j.clinre.2018.07.010.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4 suppl","key":"2262_CR8","first-page":"p526A","volume":"60","author":"L Abetz-Webb","year":"2014","unstructured":"Abetz-Webb L, Kennedy C, Hepburn B, Gauthier M, Johnson N, Madendorp S, et al. The burden of pruritus on patients with Alagille syndrome: results from a qualitative study with pediatric patients and their caregivers [abstract 673]. Hepatology. 2014;60(4 suppl):p526A-7A.","journal-title":"Hepatology"},{"key":"2262_CR9","unstructured":"U.S. Food and Drug Administration. Patient-Focused Drug Development Guidance Public Workshop: Methods to Identify What is Important to Patients & Select, Develop or Modify Fit-for Purpose Clinical Outcomes Assessments. 2018. https:\/\/www.fda.gov\/media\/116281\/download. Accessed 14 June 2022."},{"key":"2262_CR10","unstructured":"U.S. Department of Health and Human Services. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM193282.pdf. Accessed 13 June 2022."},{"issue":"9","key":"2262_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","volume":"7","author":"RJ Thompson","year":"2022","unstructured":"Thompson RJ, Arnell H, Artan R, Baumann U, Calvo PL, Czubkowski P, et al. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2022;7(9):830\u201342. https:\/\/doi.org\/10.1016\/S2468-1253(22)00093-0.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"8","key":"2262_CR12","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800\u201312. https:\/\/doi.org\/10.1097\/00005650-200108000-00006.","journal-title":"Med Care"},{"issue":"2","key":"2262_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155\u201363. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012.","journal-title":"J Chiropr Med"},{"key":"2262_CR14","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Lawrence Erlbaum Associates; 1988.","edition":"2"},{"key":"2262_CR15","unstructured":"Committee for Medicinal Products for Human Use. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. 2005. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-regulatory-guidance-use-healthrelated-quality-life-hrql-measures-evaluation_en.pdf. Accessed 13 June 2022."},{"key":"2262_CR16","volume-title":"Psychometric theory 3E","author":"JC Nunnally","year":"1994","unstructured":"Nunnally JC, Bernstein IH. Psychometric theory 3E. 3rd ed. New York: Tata McGraw-Hill Education; 1994.","edition":"3"},{"issue":"1 suppl","key":"2262_CR17","first-page":"284A","volume":"64","author":"D Serrano","year":"2016","unstructured":"Serrano D, Gauthier M, Harrington M, Acevedo L. Psychometric validation of the Itch-Reported Outcome (ItchRO\u2122) assessment in pediatric patients with Alagille syndrome or progressive familial intrahepatic cholestasis [abstract 571]. Hepatology. 2016;64(1 suppl):284A-A285.","journal-title":"Hepatology"},{"issue":"1","key":"2262_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40271-017-0266-4","volume":"11","author":"BM Kamath","year":"2018","unstructured":"Kamath BM, Abetz-Webb L, Kennedy C, Hepburn B, Gauthier M, Johnson N, et al. Development of a novel tool to assess the impact of itching in pediatric cholestasis. Patient. 2018;11(1):69\u201382. https:\/\/doi.org\/10.1007\/s40271-017-0266-4.","journal-title":"Patient"},{"issue":"2","key":"2262_CR19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/hep.31787","volume":"74","author":"DBE van Wessel","year":"2021","unstructured":"van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Shneider BL, Sokal E, et al. Impact of genotype, serum bile acids, and surgical biliary diversion on native liver survival in FIC1 deficiency. Hepatology. 2021;74(2):892\u2013906. https:\/\/doi.org\/10.1002\/hep.31787.","journal-title":"Hepatology"},{"issue":"11","key":"2262_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/diagnostics10110907","volume":"10","author":"MD Ayoub","year":"2020","unstructured":"Ayoub MD, Kamath BM. Alagille syndrome: diagnostic challenges and advances in management. Diagnostics (Basel, Switzerland). 2020;10(11):907. https:\/\/doi.org\/10.3390\/diagnostics10110907.","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"suppl 1","key":"2262_CR21","first-page":"S49","volume":"73","author":"B Dalgic","year":"2021","unstructured":"Dalgic B, Verkade H, Lachaux A, Baumann U, D\u2019Antiga L, Czubkowski P, et al. Relationships between decreases in serum bile acids, pruritus, and sleep disturbance scores with up to 72 weeks of odevixibat treatment in patients with progressive familial intrahepatic cholestasis [abstract 69]. J Pediatr Gastroenterol Nutr. 2021;73(suppl 1):S49\u201350.","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02262-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02262-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02262-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T11:49:25Z","timestamp":1664538565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02262-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["2262"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02262-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"26 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}